(Q21144663)

16 August 2022

Steven Joffe

6

Steven

Joffe

1 reference

16 August 2022

7

Nancy Kass

Nancy

Kass

1 reference

16 August 2022

5

Christine Grady

Christine

Grady

1 reference

16 August 2022

15

Benjamin S Wilfond

Benjamin S

Wilfond

1 reference

16 August 2022

10

Franklin G Miller

Franklin G

Miller

1 reference

16 August 2022

9

Charles W Lidz

Charles W

Lidz

1 reference

16 August 2022

Gail E Henderson

1

Gail E

Henderson

1 reference

16 August 2022

Larry R Churchill

2

Larry R

Churchill

1 reference

16 August 2022

Michele M Easter

4

Michele M

Easter

1 reference

16 August 2022

Nancy M P King

8

Nancy M P

King

1 reference

16 August 2022

Daniel K Nelson

11

Daniel K

Nelson

1 reference

16 August 2022

Jeffrey Peppercorn

12

Jeffrey

Peppercorn

1 reference

16 August 2022

Barbra Bluestone Rothschild

13

Barbra Bluestone

Rothschild

1 reference

16 August 2022

Pamela Sankar

14

Pamela

Sankar

1 reference

16 August 2022

Catherine R Zimmer

16

Catherine R

Zimmer

1 reference

Creative Commons CC0 License

16 August 2022

language of work or name

English

0 references

publication date

27 November 2007

0 references

published in

PLOS MEDICINE

0 references

volume

4

0 references

issue

11

0 references

page(s)

e324

0 references

copyright license

start time

27 November 2007

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted, dedicated to the public domain by copyright holder

0 references

cites work

The Belmont Report. Ethical principles and guidelines for the protection of human subjects of research

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082641

Re-evaluating the therapeutic misconception: response to Miller and Joffe.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082641

Confronting the issues of therapeutic misconception, enrollment decisions, and personal motives in genetic medicine-based clinical research studies for fatal disorders

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082641

Systematic review to determine whether participation in a trial influences outcome

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082641

Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082641

Assessing Benefits in Clinical Research: Why Diversity in Benefit Assessment Can Be Risky

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082641

A critique of clinical equipoise. Therapeutic misconception in the ethics of clinical trials

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082641

Misunderstanding in clinical research: distinguishing therapeutic misconception, therapeutic misestimation, and therapeutic optimism

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082641

The invisible hand in clinical research: the study coordinator's critical role in human subjects protection

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082641

The therapeutic misconception: problems and solutions

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082641

Quality of informed consent in cancer clinical trials: a cross-sectional survey

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082641

Defining and describing benefit appropriately in clinical trials

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082641

Are randomized clinical trials good for us (in the short term)? Evidence for a "trial effect".

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082641

The therapeutic misconception: informed consent in psychiatric research

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082641

False hopes and best data: consent to research and the therapeutic misconception

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082641

Views of American oncologists about the purposes of clinical trials

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082641

Phase I cancer trials. A collusion of misunderstanding.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082641

The impact of disease severity on the informed consent process in clinical research.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082641

Evaluating the therapeutic misconception

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082641

The many meanings of care in clinical research

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082641

Rethinking Risk-Benefit Assessment for Phase I Cancer Trials

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082641

Assessment of therapeutic misconception in older schizophrenia patients with a brief instrument.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082641

Evaluating the quality of informed consent

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082641

Vulnerability to Influence: A Two-Way Street

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082641

Consensus and controversy in clinical research ethics

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082641

Therapeutic misconception in early phase gene transfer trials

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082641

Elements of style: consent form language and the therapeutic misconception in phase 1 gene transfer trials

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082641

Consent forms and the therapeutic misconception: the example of gene transfer research

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082641

Uncertain benefit: investigators' views and communications in early phase gene transfer trials.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082641

The correlation between patient characteristics and expectations of benefit from Phase I clinical trials

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082641

The ubiquity and utility of the therapeutic misconception

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082641

Quantitative analysis of ethical issues in phase I trials: a survey interview of 144 advanced cancer patients.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082641

Rewriting the "points to consider": the ethical impact of guidance document language

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082641

Trust, The fragile foundation of contemporary biomedical research

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082641

Therapeutic misconception and the appreciation of risks in clinical trials

29 November 2018

1 reference

12 December 2020

Therapeutic misconception in clinical research: frequency and risk factors

1 reference

12 December 2020

Communication and miscommunication in informed consent to research

1 reference

12 December 2020

The "inclusion benefit" in clinical trials

1 reference

12 December 2020

10.1371/JOURNAL.PMED.0040324

Identifiers

DOI

1 reference

1 reference

1 reference

1 reference